A review on the role of DANCR in the carcinogenesis.
Cancer
DANCR
lncRNA
Journal
Cancer cell international
ISSN: 1475-2867
Titre abrégé: Cancer Cell Int
Pays: England
ID NLM: 101139795
Informations de publication
Date de publication:
19 May 2022
19 May 2022
Historique:
received:
14
03
2022
accepted:
06
05
2022
entrez:
19
5
2022
pubmed:
20
5
2022
medline:
20
5
2022
Statut:
epublish
Résumé
DANCR is an RNA gene located on chr4. This gene has several splice variants. Up-regulation of DANCR has been reported in many types of cancers. This lncRNA is mainly located in the cytoplasm and regulates genes expression at post-transcriptional level. In fact, it acts as a molecular sponge for a variety of miRNAs, including miR-874-3P, miR-335, miR-149, miR-4319, miR-758-3p, miR-216a-5p, miR-874-3p, miR-33a-5p, miR-335-5p, miR-145-3p, miR-665, miR-345-5p and miR-125b-5p. DANCR also regulates activity of PI3K/AKT/NF-κB, Wnt/β-catenin, ERK/SMAD, MAPK, IL-6/JAK1/STAT3, Smad2/3, p53, FAK/PI3K/AKT/GSK3β/Snail pathways. In the current narrative review article, we summarize the roles of DANCR in the carcinogenesis, with an especial emphasis on its role in the development of osteosarcoma and lung, liver, pancreatic and colorectal cancers.
Identifiants
pubmed: 35590326
doi: 10.1186/s12935-022-02612-z
pii: 10.1186/s12935-022-02612-z
pmc: PMC9118872
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
194Informations de copyright
© 2022. The Author(s).
Références
Int J Clin Exp Pathol. 2015 Sep 01;8(9):11480-4
pubmed: 26617879
Pathol Res Pract. 2018 Jun;214(6):801-805
pubmed: 29728310
Mol Med Rep. 2021 Sep;24(3):
pubmed: 34278459
Front Oncol. 2020 Jul 17;10:1034
pubmed: 32766131
Kaohsiung J Med Sci. 2021 May;37(5):371-378
pubmed: 33089960
Hum Cell. 2020 Oct;33(4):1281-1293
pubmed: 32860589
Exp Ther Med. 2018 Nov;16(5):4246-4252
pubmed: 30344699
Neuroreport. 2021 Aug 11;32(12):965-974
pubmed: 34050113
Transl Cancer Res. 2019 Nov;8(7):2517-2525
pubmed: 35117008
Eur J Pharmacol. 2019 Oct 15;861:172590
pubmed: 31401160
Front Cell Dev Biol. 2022 Jan 12;9:784719
pubmed: 35096816
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2539-2547
pubmed: 32196604
Cancer Lett. 2017 Oct 1;405:46-55
pubmed: 28642170
Med Sci Monit. 2020 Jul 19;26:e923622
pubmed: 32683392
Theranostics. 2018 Nov 10;8(20):5676-5689
pubmed: 30555573
Cell Prolif. 2019 Jul;52(4):e12628
pubmed: 31038266
Biol Open. 2017 Sep 15;6(9):1310-1316
pubmed: 28760736
Cell Death Dis. 2018 Dec 5;9(12):1167
pubmed: 30518934
Cell Signal. 2020 Mar;67:109502
pubmed: 31863900
Onco Targets Ther. 2020 Feb 05;13:1145-1157
pubmed: 32103983
Am J Transl Res. 2021 Apr 15;13(4):2224-2240
pubmed: 34017385
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2794-2802
pubmed: 31002130
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):758-769
pubmed: 33577030
Cancer Cell Int. 2020 Feb 22;20:61
pubmed: 32123519
Tumori. 2021 Dec;107(6):504-513
pubmed: 33272103
Cell Cycle. 2021 Jul;20(14):1441-1454
pubmed: 34233586
Med Sci Monit. 2019 Jun 19;25:4544-4552
pubmed: 31213582
Crit Rev Eukaryot Gene Expr. 2020;30(5):447-456
pubmed: 33389881
Biosci Rep. 2020 Mar 27;40(3):
pubmed: 32159208
Mol Biol Rep. 2021 Apr;48(4):3541-3547
pubmed: 33956301
Cancer Sci. 2019 Mar;110(3):913-925
pubmed: 30582654
Cell Death Dis. 2021 Jan 6;12(1):24
pubmed: 33414433
Neurochem Int. 2018 Sep;118:233-241
pubmed: 29572052
Am J Pathol. 2020 Dec;190(12):2343-2354
pubmed: 32971057
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10657-10663
pubmed: 31858532
Oncotarget. 2017 Dec 6;9(2):1915-1930
pubmed: 29416741
J Cell Physiol. 2019 May;234(5):7266-7278
pubmed: 30362591
Biosci Rep. 2019 Apr 23;39(4):
pubmed: 30910842
Hepatology. 2016 Feb;63(2):499-511
pubmed: 25964079
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6849-6857
pubmed: 31486484
Cell Death Dis. 2019 Aug 5;10(8):585
pubmed: 31383847
Biosci Rep. 2018 Feb 2;38(1):
pubmed: 29301870
Cancer Cell Int. 2019 Nov 19;19:302
pubmed: 31827393
Cell Death Dis. 2019 May 9;10(5):373
pubmed: 31073122
Am J Cancer Res. 2019 Feb 01;9(2):270-284
pubmed: 30906628
Mol Med Rep. 2019 Apr;19(4):2883-2889
pubmed: 30720067
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6551-6560
pubmed: 32633342
Oncol Rep. 2019 Feb;41(2):1083-1090
pubmed: 30535487
Tumour Biol. 2017 Jun;39(6):1010428317699798
pubmed: 28618943
Biochem Biophys Res Commun. 2020 Jan 8;521(2):271-278
pubmed: 31635802
Mol Oncol. 2021 Apr;15(4):1203-1216
pubmed: 33638615
J Exp Clin Cancer Res. 2018 Nov 12;37(1):273
pubmed: 30419948
Onco Targets Ther. 2020 Apr 08;13:3013-3024
pubmed: 32308432
Mol Biol Rep. 2022 Apr;49(4):2821-2829
pubmed: 35066769
Anticancer Res. 2016 Dec;36(12):6389-6398
pubmed: 27919960
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2321-2334
pubmed: 32196584
Onco Targets Ther. 2019 Jul 09;12:5485-5497
pubmed: 31371987
Cancer Control. 2018 Jan-Mar;25(1):1073274818769849
pubmed: 29651883
J Thorac Dis. 2018 May;10(5):2573-2582
pubmed: 29997918
Onco Targets Ther. 2018 Dec 21;12:135-146
pubmed: 30613152
J Cell Physiol. 2018 Oct;233(10):6986-6995
pubmed: 29744877
Med Sci Monit. 2020 May 17;26:e922760
pubmed: 32417846
J Cell Mol Med. 2018 Mar;22(3):1527-1537
pubmed: 29266795
BMC Cancer. 2020 May 18;20(1):434
pubmed: 32423468
Exp Cell Res. 2020 Nov 15;396(2):112331
pubmed: 33058834
Transl Androl Urol. 2021 Apr;10(4):1743-1753
pubmed: 33968662
Biomolecules. 2020 Dec 08;10(12):
pubmed: 33302540
Onco Targets Ther. 2018 Nov 09;11:7955-7965
pubmed: 30519037
J Gene Med. 2021 Jul;23(7):e3344
pubmed: 33885171
Mol Med Rep. 2017 Oct;16(4):4463-4468
pubmed: 28765964
J BUON. 2020 Jul-Aug;25(4):1954-1959
pubmed: 33099938
Mol Oncol. 2020 Feb;14(2):309-328
pubmed: 31860165
Biomed Pharmacother. 2018 Jun;102:602-607
pubmed: 29602127
Onco Targets Ther. 2019 Apr 04;12:2439-2449
pubmed: 31114219
NPJ Genom Med. 2021 Sep 21;6(1):75
pubmed: 34548487
Cancer Biother Radiopharm. 2020 Aug 18;:
pubmed: 32818383
Mol Cell Biochem. 2019 Oct;460(1-2):9-15
pubmed: 31161373
Cancer Cell Int. 2020 Feb 18;20:53
pubmed: 32099526
Neoplasma. 2018 Sep 19;65(5):790-798
pubmed: 29940760
Biosci Rep. 2019 Apr 17;39(4):
pubmed: 30910839
Oncol Lett. 2018 Sep;16(3):2865-2872
pubmed: 30127873
Mol Carcinog. 2019 Dec;58(12):2286-2296
pubmed: 31545000
Lab Med. 2019 Apr 8;50(2):180-188
pubmed: 30423146
Front Cell Dev Biol. 2022 Jan 24;9:659228
pubmed: 35141227
Invest New Drugs. 2020 Jun;38(3):714-721
pubmed: 31267381
Mol Cancer. 2018 May 12;17(1):89
pubmed: 29753317
Cell Death Dis. 2020 Apr 27;11(4):296
pubmed: 32341351
Oncotarget. 2016 Jun 21;7(25):37868-37881
pubmed: 27191265
Bioconjug Chem. 2019 Mar 20;30(3):907-919
pubmed: 30739442
FEBS Open Bio. 2020 Jan;10(1):18-27
pubmed: 31515968
J Cell Physiol. 2019 Jun;234(6):9408-9416
pubmed: 30430564
J Clin Lab Anal. 2022 Mar;36(3):e24186
pubmed: 35150011
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):8778-8787
pubmed: 32964966
J Biochem. 2022 Mar 31;171(4):389-398
pubmed: 33481014
Mol Med Rep. 2022 Apr;25(4):
pubmed: 35147200
Biomed Pharmacother. 2018 Jul;103:94-100
pubmed: 29635134
Mol Ther. 2019 Feb 6;27(2):326-341
pubmed: 30660488